COMP <GO>
AVTR vs LLY // EV/EBITDA & P/E VALUATION
Avantor Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: AVTR 2
— LLY 12
■ METRIC PARITY
LAST: $16.05 (-3.78%) • MKT CAP: $11.30B
valuation
—
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
valuation
36.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVTR VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVTR | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.70% | 83.64% | -50.94 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.10% | 32.36% | -34.46 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.38% | 2.30% | +2.08 | AVTR | /fcf-yield <GO> |
| Operating Margin | -3.80% | 40.21% | -44.01 | LLY | /operating-margins <GO> |
| Net Profit Margin | -8.10% | 31.90% | -40.00 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | -3.40% | 45.51% | -48.91 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 9.29 | -7.41 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.77% | +0.13 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 77.9 | -28.78 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.51 | +0.50 | AVTR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 26.3x | +4.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.30B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVTR REV | LLY REV | AVTR GROSS % | LLY GROSS % | AVTR FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.55B | $65.18B | 32.7% | 83.0% | $495.0M | $16.81B |
| FY 2024 | $6.78B | $45.04B | 33.6% | 81.3% | $692.0M | $8.82B |
| FY 2023 | $6.97B | $34.12B | 44.0% | 79.3% | $556.5M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVTR // BETA 1.01
LLY // BETA 0.51